Autentificare
NeuroPsy InfoHubÎnțelege · Sprijin · ProgresCere sprijin
← Toate temele

Depresie

Tristețe persistentă, lipsa energiei și a motivației.

110 articole
← Toate secțiunile

Studii și știri

PublicToțiPentru oricineSpecialiști
VârstăToate vârsteleCopiiTineriAdulțiVârstnici
StudiuDepresieÎncredere înaltă15.06.2026

Baseline Depressive Symptom Profiles Associated with Remission in Major Depression: PANDORA Trial Analysis

This secondary analysis of 215 adults with major depression found that 53% achieved remission at 12 weeks on antidepressants, with higher baseline severity and specific symptoms (suicidal ideation, psychomotor retardation, hypochondriasis) predicting lower remission odds. Sex differences emerged, with psychomotor retardation and suicidal ideation predicting non-remission in women, while hypochondriasis was the key marker in men.

StudiuDepresieÎncredere înaltă15.06.2026

Fluoxetine-induced neurogenesis and chronic antidepressant effects requires the dopamine D2 receptor

This study demonstrates that the dopamine D2 receptor (D2R) is essential for the long-term therapeutic effects of fluoxetine (an SSRI) on mood and hippocampal neurogenesis in mouse models of depression. The research reveals that D2R signaling through beta-arrestin 2 and BDNF regulation is crucial for chronic antidepressant action, though not required for acute responses to the drug.

StudiuDepresieÎncredere înaltă15.06.2026

Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder: Neurobiological Mechanisms and Clinical Translation

This scoping review examines scientific evidence for rTMS and related techniques (theta-burst stimulation, deep TMS) as therapeutic approaches for treatment-resistant depression, evaluating their effectiveness and safety across clinical trials and laboratory studies. rTMS applied to the prefrontal cortex demonstrates significant antidepressant effects with generally mild, transient adverse effects, and research indicates it produces neurobiological changes in brain connectivity and neurotransmitter systems.

StudiuDepresieÎncredere înaltă15.06.2026

A Review of Translational Behavioral Assays in Depression Research

This systematic review identified 10 behavioral tests with comparable human and rodent versions that measure depressive symptoms across species, including assays of valence systems, affective bias, and cognitive function. The translational approach bridges animal and human research paradigms to advance understanding of depression neurobiology and improve treatment development.

StudiuDepresieÎncredere înaltă15.06.2026

Elevated serotonin 1A receptor binding in borderline personality disorder with depression appears driven by mood disorder, not BPD

This PET imaging study compared serotonin 1A receptor binding across individuals with mood disorders (with/without borderline personality disorder) and healthy controls. Results indicate that elevated serotonin 1A receptor binding is associated with mood disorders rather than borderline personality disorder itself, suggesting distinct neurobiological mechanisms for each condition.

StudiuDepresieCredibilitate scăzută15.06.2026

Critical Appraisal of Ketogenic Diet as Adjunct Therapy for College Students with Major Depressive Disorder

A critical review of a 16-person pilot study found that a well-formulated ketogenic diet over 10-12 weeks showed associations with significant reductions in depression scores (69-71%) and improvements in cognitive function and metabolic markers. The authors appropriately emphasize limitations of the uncontrolled design and call for larger randomized controlled trials to establish causality and explore mechanisms.

StudiuDepresieÎncredere înaltă15.06.2026

Circadian Rhythms in Major Depressive Disorder: Mechanistic Insights and Therapeutic Frontiers

This review examines how disruption of circadian rhythms contributes to major depressive disorder through dysregulation of sleep-wake cycles, mood patterns, and genetic variants in clock genes (CLOCK, TIMELESS, CRY1), along with abnormal HPA axis and melatonin signaling. Emerging evidence supports chronotherapeutic approaches such as light therapy and targeted sleep interventions as evidence-based treatments that could be personalized using genetic and molecular markers.

StudiuDepresieÎncredere înaltă15.06.2026

Geriatric Depression Presenting as Pseudoparkinsonism: A Levodopa-Responsive Case With 3-Year Follow-Up

A woman in her 60s with recurrent depression developed severe psychomotor retardation mimicking Parkinson's disease, including tremor and rigidity unresponsive to standard antidepressants. Levodopa produced marked improvement in both motor and depressive symptoms, while a normal dopamine transporter scan ruled out neurodegeneration, confirming the diagnosis of geriatric depression with pseudoparkinsonism.

StudiuDepresieÎncredere înaltă15.06.2026

Top 50 Cited Articles on the Treatment of Major Depressive Disorder: A Bibliometric Analysis

This bibliometric study analyzes the 50 most-cited research articles on major depressive disorder treatment between 1989-2018, examining publication patterns, study designs, and geographic distribution. The review identifies that randomized controlled trials and meta-analyses dominate the influential literature, with significant contributions from the United States, Canada, and the United Kingdom.

StudiuDepresieÎncredere bună15.06.2026

The major biogenic amine metabolites in mood disorders

This review examines the relationship between mood disorders (major depression and bipolar disorder) and alterations in biogenic amine metabolites such as histamine, kynurenine, and creatine. The authors propose that understanding these biochemical changes could improve diagnosis, inform treatment development, and clarify biological mechanisms underlying mood disorders.

PresăDepresieÎncredere bună07.06.2026

Tracking Depression: New Fluorescent Probe for Serotonin Imaging

Researchers have developed a highly sensitive and selective fluorescent probe for imaging serotonin, which is relevant to understanding depression diagnosis, treatment, and drug development. This tool enables better visualization of serotonin-related biological processes in depression research.

PresăDepresieÎncredere bună06.06.2026

Too much sleep can hurt cognitive performance, especially for those with depression

Research demonstrates that sleeping nine or more hours nightly correlates with reduced cognitive performance, with this effect amplified in individuals with depression. The finding aligns with established understanding of hypersomnia as a depressive symptom with measurable cognitive consequences.

StudiuDepresieÎncredere bună06.06.2026

An Uncertainty-Aware Ensemble of Support Vector Machine and Gaussian Process Models for Maternal Mental Health Risk Prediction Using Psychosocial and Clinical Risk Factors

Study develops an uncertainty-aware ensemble machine learning model combining SVM and Gaussian Process algorithms to predict postpartum depression risk using clinical and psychosocial factors from multicountry datasets. Random Forest achieved highest accuracy (97.75%), while the proposed hybrid model demonstrated superior uncertainty calibration for clinical reliability.

PresăDepresieVerificat editorial05.06.2026

Popular hair-loss pill linked to depression and suicide

Finasteride (hair-loss medication) has documented associations with depression and suicidal ideation in post-marketing data. The article argues regulators have inadequately addressed these psychiatric risks despite evidence.